APO Research
Talk to an analyst

APO RESEARCH · REPORT

Receptor Tyrosine Protein Kinase ERBB 3

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Receptor Tyrosine Protein Kinase ERBB 3 Industry Growth and Trends Forecast to 2032

26 December 2025113 pages

Choose your research edition.

Industry ResearchReceptor Tyrosine Protein Kinase ERBB 3 Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Receptor Tyrosine Protein Kinase ERBB 3 Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Receptor Tyrosine Protein Kinase ERBB 3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Receptor Tyrosine Protein Kinase ERBB 3 Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Receptor Tyrosine Protein Kinase ERBB 3 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Receptor Tyrosine Protein Kinase ERBB 3 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Receptor Tyrosine Protein Kinase ERBB 3 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Receptor Tyrosine Protein Kinase ERBB 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Receptor Tyrosine Protein Kinase ERBB 3 include Novartis AG, GlaxoSmithKline Plc, AstraZeneca Plc, Takis S.r.l., Symphogen A/S, Sorrento Therapeutics, Inc., Sihuan Pharmaceutical Holdings Group Ltd., Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Merus B.V., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Receptor Tyrosine Protein Kinase ERBB 3 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Receptor Tyrosine Protein Kinase ERBB 3 market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Receptor Tyrosine Protein Kinase ERBB 3 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Receptor Tyrosine Protein Kinase ERBB 3.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Receptor Tyrosine Protein Kinase ERBB 3 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Receptor Tyrosine Protein Kinase ERBB 3 Market by Company

Novartis AG

GlaxoSmithKline Plc

AstraZeneca Plc

Takis S.r.l.

Symphogen A/S

Sorrento Therapeutics, Inc.

Sihuan Pharmaceutical Holdings Group Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Merus B.V.

Merrimack Pharmaceuticals, Inc.

Kolltan Pharmaceuticals, Inc.

ImmunoGen, Inc.

Hanmi Pharmaceuticals, Co. Ltd.

GamaMabs Pharma S.A.

F. Hoffmann-La Roche Ltd.

Etubics Corporation

AVEO Pharmaceuticals, Inc.

Receptor Tyrosine Protein Kinase ERBB 3 Segment by Type

BA-0702

CDX-3379

Elgemtumab

ETBX-031

Others

Receptor Tyrosine Protein Kinase ERBB 3 Segment by Application

Non-Small Cell Carcinoma

Solid Tumor

Melanoma

Colorectal Cancer

Others

Receptor Tyrosine Protein Kinase ERBB 3 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Receptor Tyrosine Protein Kinase ERBB 3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Receptor Tyrosine Protein Kinase ERBB 3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Receptor Tyrosine Protein Kinase ERBB 3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Receptor Tyrosine Protein Kinase ERBB 3 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Receptor Tyrosine Protein Kinase ERBB 3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of BA-0702 Table 2. Major Company of CDX-3379 Table 3. Major Company of Elgemtumab Table 4. Major Company of ETBX-031 Table 5. Major Company of Others Table 6. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (K Units) Table 8. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Type (2021-2026) Table 9. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (US$ Million) Table 10. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Type (2021-2026) Table 11. Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Type (2021-2026) & (US$/Unit) Table 12. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2027-2032) & (K Units) Table 13. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Type (2027-2032) Table 14. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2027-2032) & (US$ Million) Table 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Type (2027-2032) Table 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Type (2027-2032) & (US$/Unit) Table 17. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (K Units) Table 18. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (K Units) Table 20. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (K Units) Table 24. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2021-2026) & (US$ Million) Table 27. Receptor Tyrosine Protein Kinase ERBB 3 Industry Trends Table 28. Receptor Tyrosine Protein Kinase ERBB 3 Industry Drivers Table 29. Receptor Tyrosine Protein Kinase ERBB 3 Industry Opportunities and Challenges Table 30. Receptor Tyrosine Protein Kinase ERBB 3 Industry Restraints Table 31. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Company (2021-2026) Table 33. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Company (2021-2026) & (K Units) Table 34. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Company (2021-2026) Table 35. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Receptor Tyrosine Protein Kinase ERBB 3 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Receptor Tyrosine Protein Kinase ERBB 3 Major Company Production Sites and Headquarters Table 38. Global Receptor Tyrosine Protein Kinase ERBB 3 Company, Product Type & Application Table 39. Global Receptor Tyrosine Protein Kinase ERBB 3 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Receptor Tyrosine Protein Kinase ERBB 3 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2021-2026) & (K Units) Table 44. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Region (2021-2026) Table 45. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2021-2026) & (US$ Million) Table 46. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Region (2021-2026) Table 47. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2027-2032) & (K Units) Table 49. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Region (2027-2032) Table 50. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2027-2032) & (US$ Million) Table 51. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Region (2027-2032) Table 52. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (K Units) Table 55. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Application (2021-2026) Table 56. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (US$ Million) Table 57. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Application (2021-2026) Table 58. Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Application (2021-2026) & (US$/Unit) Table 59. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2027-2032) & (K Units) Table 60. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Application (2027-2032) Table 61. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2027-2032) & (US$ Million) Table 62. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Application (2027-2032) Table 63. Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Application (2027-2032) & (US$/Unit) Table 64. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (K Units) Table 65. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (K Units) Table 67. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (K Units) Table 71. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2021-2026) & (US$ Million) Table 74. Novartis AG Company Information Table 75. Novartis AG Business Overview Table 76. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 78. Novartis AG Recent Development Table 79. GlaxoSmithKline Plc Company Information Table 80. GlaxoSmithKline Plc Business Overview Table 81. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 83. GlaxoSmithKline Plc Recent Development Table 84. AstraZeneca Plc Company Information Table 85. AstraZeneca Plc Business Overview Table 86. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 88. AstraZeneca Plc Recent Development Table 89. Takis S.r.l. Company Information Table 90. Takis S.r.l. Business Overview Table 91. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 93. Takis S.r.l. Recent Development Table 94. Symphogen A/S Company Information Table 95. Symphogen A/S Business Overview Table 96. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 98. Symphogen A/S Recent Development Table 99. Sorrento Therapeutics, Inc. Company Information Table 100. Sorrento Therapeutics, Inc. Business Overview Table 101. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 103. Sorrento Therapeutics, Inc. Recent Development Table 104. Sihuan Pharmaceutical Holdings Group Ltd. Company Information Table 105. Sihuan Pharmaceutical Holdings Group Ltd. Business Overview Table 106. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 108. Sihuan Pharmaceutical Holdings Group Ltd. Recent Development Table 109. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Company Information Table 110. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Business Overview Table 111. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 113. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Development Table 114. Merus B.V. Company Information Table 115. Merus B.V. Business Overview Table 116. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 118. Merus B.V. Recent Development Table 119. Merrimack Pharmaceuticals, Inc. Company Information Table 120. Merrimack Pharmaceuticals, Inc. Business Overview Table 121. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 123. Merrimack Pharmaceuticals, Inc. Recent Development Table 124. Kolltan Pharmaceuticals, Inc. Company Information Table 125. Kolltan Pharmaceuticals, Inc. Business Overview Table 126. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 128. Kolltan Pharmaceuticals, Inc. Recent Development Table 129. ImmunoGen, Inc. Company Information Table 130. ImmunoGen, Inc. Business Overview Table 131. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 133. ImmunoGen, Inc. Recent Development Table 134. Hanmi Pharmaceuticals, Co. Ltd. Company Information Table 135. Hanmi Pharmaceuticals, Co. Ltd. Business Overview Table 136. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 138. Hanmi Pharmaceuticals, Co. Ltd. Recent Development Table 139. GamaMabs Pharma S.A. Company Information Table 140. GamaMabs Pharma S.A. Business Overview Table 141. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 143. GamaMabs Pharma S.A. Recent Development Table 144. F. Hoffmann-La Roche Ltd. Company Information Table 145. F. Hoffmann-La Roche Ltd. Business Overview Table 146. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 148. F. Hoffmann-La Roche Ltd. Recent Development Table 149. Etubics Corporation Company Information Table 150. Etubics Corporation Business Overview Table 151. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 153. Etubics Corporation Recent Development Table 154. AVEO Pharmaceuticals, Inc. Company Information Table 155. AVEO Pharmaceuticals, Inc. Business Overview Table 156. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio Table 158. AVEO Pharmaceuticals, Inc. Recent Development Table 159. North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026) & (K Units) Table 161. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2021-2026) Table 162. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2027-2032) & (K Units) Table 163. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Country (2027-2032) Table 164. North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country (2021-2026) & (US$ Million) Table 166. North America Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Country (2021-2026) Table 167. North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. North America Receptor Tyrosine Protein Kinase ERBB 3 Market Share Forecast by Country (2027-2032) Table 169. Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 170. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026) & (K Units) Table 171. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2021-2026) Table 172. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2027-2032) & (K Units) Table 173. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Country (2027-2032) Table 174. Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country (2021-2026) & (US$ Million) Table 176. Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Country (2021-2026) Table 177. Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Share Forecast by Country (2027-2032) Table 179. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 180. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026) & (K Units) Table 181. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2021-2026) Table 182. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2027-2032) & (K Units) Table 183. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Country (2027-2032) Table 184. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country (2021-2026) & (US$ Million) Table 186. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Country (2021-2026) Table 187. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Share Forecast by Country (2027-2032) Table 189. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 190. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026) & (K Units) Table 191. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2021-2026) Table 192. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2027-2032) & (K Units) Table 193. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Country (2027-2032) Table 194. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 195. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country (2021-2026) & (US$ Million) Table 196. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Country (2021-2026) Table 197. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 198. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Share Forecast by Country (2027-2032) Table 199. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 200. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026) & (K Units) Table 201. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2021-2026) Table 202. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2027-2032) & (K Units) Table 203. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Country (2027-2032) Table 204. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 205. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country (2021-2026) & (US$ Million) Table 206. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Country (2021-2026) Table 207. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 208. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Share Forecast by Country (2027-2032) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Receptor Tyrosine Protein Kinase ERBB 3 Distributors List Table 212. Receptor Tyrosine Protein Kinase ERBB 3 Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Receptor Tyrosine Protein Kinase ERBB 3 Image Figure 2. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size (2021-2032) & (US$ Million) Figure 4. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (2021-2032) & (K Units) Figure 5. BA-0702 Image Figure 6. Global BA-0702 Sales YoY Growth (2021-2032) & (K Units) Figure 7. CDX-3379 Image Figure 8. Global CDX-3379 Sales YoY Growth (2021-2032) & (K Units) Figure 9. Elgemtumab Image Figure 10. Global Elgemtumab Sales YoY Growth (2021-2032) & (K Units) Figure 11. ETBX-031 Image Figure 12. Global ETBX-031 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Type 2025 VS 2032 Figure 17. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Type in 2025 Figure 18. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Type in 2025 Figure 19. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Type in 2025 Figure 20. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Type in 2025 Figure 23. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Receptor Tyrosine Protein Kinase ERBB 3 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Non-Small Cell Carcinoma Image Figure 30. Global Non-Small Cell Carcinoma Sales YoY Growth (2021-2032) & (K Units) Figure 31. Solid Tumor Image Figure 32. Global Solid Tumor Sales YoY Growth (2021-2032) & (K Units) Figure 33. Melanoma Image Figure 34. Global Melanoma Sales YoY Growth (2021-2032) & (K Units) Figure 35. Colorectal Cancer Image Figure 36. Global Colorectal Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Application 2025 VS 2032 Figure 41. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Application in 2025 Figure 42. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Application in 2025 Figure 43. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Application in 2025 Figure 44. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Application in 2025 Figure 47. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share in Value by Application in 2025 Figure 51. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Receptor Tyrosine Protein Kinase ERBB 3 Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Receptor Tyrosine Protein Kinase ERBB 3 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • BA-0702
  • CDX-3379
  • Elgemtumab
  • ETBX-031
  • Others
Applications
  • Non-Small Cell Carcinoma
  • Solid Tumor
  • Melanoma
  • Colorectal Cancer
  • Others
Companies covered
  • Novartis AG
  • GlaxoSmithKline Plc
  • AstraZeneca Plc
  • Takis S.r.l.
  • Symphogen A/S
  • Sorrento Therapeutics, Inc.
  • Sihuan Pharmaceutical Holdings Group Ltd.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  • Merus B.V.
  • Merrimack Pharmaceuticals, Inc.
  • Kolltan Pharmaceuticals, Inc.
  • ImmunoGen, Inc.
  • Hanmi Pharmaceuticals, Co. Ltd.
  • GamaMabs Pharma S.A.
  • F. Hoffmann-La Roche Ltd.
  • Etubics Corporation
  • AVEO Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Receptor Tyrosine Protein Kinase ERBB 3 Market by Type
  6. 1.3.1 BA-0702
  7. 1.3.2 CDX-3379
  8. 1.3.3 Elgemtumab
  9. 1.3.4 ETBX-031
  10. 1.3.5 Others
  11. 1.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Type
  12. 1.4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Receptor Tyrosine Protein Kinase ERBB 3 Industry Trends
  2. 2.2 Receptor Tyrosine Protein Kinase ERBB 3 Industry Drivers
  3. 2.3 Receptor Tyrosine Protein Kinase ERBB 3 Industry Opportunities and Challenges
  4. 2.4 Receptor Tyrosine Protein Kinase ERBB 3 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2021-2026)
  2. 3.2 Global Top Players by Receptor Tyrosine Protein Kinase ERBB 3 Sales (2021-2026)
  3. 3.3 Global Top Players by Receptor Tyrosine Protein Kinase ERBB 3 Price (2021-2026)
  4. 3.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Receptor Tyrosine Protein Kinase ERBB 3 Major Company Production Sites & Headquarters
  6. 3.6 Global Receptor Tyrosine Protein Kinase ERBB 3 Company, Product Type & Application
  7. 3.7 Global Receptor Tyrosine Protein Kinase ERBB 3 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Receptor Tyrosine Protein Kinase ERBB 3 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Receptor Tyrosine Protein Kinase ERBB 3 Tier 1, Tier 2, and Tier 3
4 Receptor Tyrosine Protein Kinase ERBB 3 Regional Status and Outlook
  1. 4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Historic Market Size by Region
  3. 4.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Forecasted Market Size by Region
  7. 4.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Receptor Tyrosine Protein Kinase ERBB 3 by Application
  1. 5.1 Receptor Tyrosine Protein Kinase ERBB 3 Market by Application
  2. 5.1.1 Non-Small Cell Carcinoma
  3. 5.1.2 Solid Tumor
  4. 5.1.3 Melanoma
  5. 5.1.4 Colorectal Cancer
  6. 5.1.5 Others
  7. 5.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Application
  8. 5.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 GlaxoSmithKline Plc
  8. 6.2.1 GlaxoSmithKline Plc Company Information
  9. 6.2.2 GlaxoSmithKline Plc Business Overview
  10. 6.2.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  12. 6.2.5 GlaxoSmithKline Plc Recent Developments
  13. 6.3 AstraZeneca Plc
  14. 6.3.1 AstraZeneca Plc Company Information
  15. 6.3.2 AstraZeneca Plc Business Overview
  16. 6.3.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  18. 6.3.5 AstraZeneca Plc Recent Developments
  19. 6.4 Takis S.r.l.
  20. 6.4.1 Takis S.r.l. Company Information
  21. 6.4.2 Takis S.r.l. Business Overview
  22. 6.4.3 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  24. 6.4.5 Takis S.r.l. Recent Developments
  25. 6.5 Symphogen A/S
  26. 6.5.1 Symphogen A/S Company Information
  27. 6.5.2 Symphogen A/S Business Overview
  28. 6.5.3 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  30. 6.5.5 Symphogen A/S Recent Developments
  31. 6.6 Sorrento Therapeutics, Inc.
  32. 6.6.1 Sorrento Therapeutics, Inc. Company Information
  33. 6.6.2 Sorrento Therapeutics, Inc. Business Overview
  34. 6.6.3 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  36. 6.6.5 Sorrento Therapeutics, Inc. Recent Developments
  37. 6.7 Sihuan Pharmaceutical Holdings Group Ltd.
  38. 6.7.1 Sihuan Pharmaceutical Holdings Group Ltd. Company Information
  39. 6.7.2 Sihuan Pharmaceutical Holdings Group Ltd. Business Overview
  40. 6.7.3 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  42. 6.7.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments
  43. 6.8 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  44. 6.8.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Company Information
  45. 6.8.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Business Overview
  46. 6.8.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  48. 6.8.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments
  49. 6.9 Merus B.V.
  50. 6.9.1 Merus B.V. Company Information
  51. 6.9.2 Merus B.V. Business Overview
  52. 6.9.3 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  54. 6.9.5 Merus B.V. Recent Developments
  55. 6.10 Merrimack Pharmaceuticals, Inc.
  56. 6.10.1 Merrimack Pharmaceuticals, Inc. Company Information
  57. 6.10.2 Merrimack Pharmaceuticals, Inc. Business Overview
  58. 6.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  60. 6.10.5 Merrimack Pharmaceuticals, Inc. Recent Developments
  61. 6.11 Kolltan Pharmaceuticals, Inc.
  62. 6.11.1 Kolltan Pharmaceuticals, Inc. Company Information
  63. 6.11.2 Kolltan Pharmaceuticals, Inc. Business Overview
  64. 6.11.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  66. 6.11.5 Kolltan Pharmaceuticals, Inc. Recent Developments
  67. 6.12 ImmunoGen, Inc.
  68. 6.12.1 ImmunoGen, Inc. Company Information
  69. 6.12.2 ImmunoGen, Inc. Business Overview
  70. 6.12.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  72. 6.12.5 ImmunoGen, Inc. Recent Developments
  73. 6.13 Hanmi Pharmaceuticals, Co. Ltd.
  74. 6.13.1 Hanmi Pharmaceuticals, Co. Ltd. Company Information
  75. 6.13.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
  76. 6.13.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  78. 6.13.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Developments
  79. 6.14 GamaMabs Pharma S.A.
  80. 6.14.1 GamaMabs Pharma S.A. Company Information
  81. 6.14.2 GamaMabs Pharma S.A. Business Overview
  82. 6.14.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  84. 6.14.5 GamaMabs Pharma S.A. Recent Developments
  85. 6.15 F. Hoffmann-La Roche Ltd.
  86. 6.15.1 F. Hoffmann-La Roche Ltd. Company Information
  87. 6.15.2 F. Hoffmann-La Roche Ltd. Business Overview
  88. 6.15.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  90. 6.15.5 F. Hoffmann-La Roche Ltd. Recent Developments
  91. 6.16 Etubics Corporation
  92. 6.16.1 Etubics Corporation Company Information
  93. 6.16.2 Etubics Corporation Business Overview
  94. 6.16.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  96. 6.16.5 Etubics Corporation Recent Developments
  97. 6.17 AVEO Pharmaceuticals, Inc.
  98. 6.17.1 AVEO Pharmaceuticals, Inc. Company Information
  99. 6.17.2 AVEO Pharmaceuticals, Inc. Business Overview
  100. 6.17.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Portfolio
  102. 6.17.5 AVEO Pharmaceuticals, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country
  2. 7.1.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026)
  4. 7.1.3 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country
  6. 7.2.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country (2021-2026)
  8. 7.2.3 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country
  2. 8.1.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026)
  4. 8.1.3 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country
  6. 8.2.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country
  2. 9.1.1 Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country
  6. 9.2.1 Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country
  2. 10.1.1 South America Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026)
  4. 10.1.3 South America Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country
  6. 10.2.1 South America Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country (2021-2026)
  8. 10.2.3 South America Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country
  2. 11.1.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country
  6. 11.2.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Receptor Tyrosine Protein Kinase ERBB 3 Value Chain Analysis
  2. 12.1.1 Receptor Tyrosine Protein Kinase ERBB 3 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Receptor Tyrosine Protein Kinase ERBB 3 Production Mode & Process
  7. 12.2 Receptor Tyrosine Protein Kinase ERBB 3 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Receptor Tyrosine Protein Kinase ERBB 3 Distributors
  10. 12.2.3 Receptor Tyrosine Protein Kinase ERBB 3 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst